脑机接口大战：马斯克抛“三年全脑计划”，中国企业追赶

Core Insights - The competition among leading brain-computer interface (BCI) companies is intensifying, with Neuralink announcing ambitious plans to achieve a "full brain interface" by 2028 and increase the number of electrode channels from thousands to tens of thousands [1][3][7] - The Chinese market is witnessing a shift towards invasive BCI technologies, with companies accelerating clinical trials and gaining significant attention from both the government and investors [1][6][7] Industry Developments - Neuralink's roadmap includes expanding capabilities from motor functions to language and vision, with plans to increase implanted electrodes from 3,000 in 2026 to over 25,000 by 2028 [3][10] - The focus on effective channel count rather than just the number of electrodes is emphasized, as many signals can be redundant [4][5] - The industry is experiencing a new peak in clinical progress, technology, and capital investment, driven by advancements in AI and supportive government policies [7][8][11] Company Insights - Brain Tiger Technology, founded in 2021, has become a leader in invasive BCI in China, raising significant funding and achieving notable clinical milestones, including real-time Chinese language decoding [6][8][12] - The founder of Brain Tiger, Tao Hu, highlights the importance of system-level thinking in commercializing BCI technology, contrasting it with traditional research approaches [12] - The integration of AI into BCI technology is seen as a key factor for future advancements, enabling better data analysis and potential direct brain-to-AI interactions [11][12]